A detailed history of Wedgewood Investors Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wedgewood Investors Inc holds 1,000 shares of VRTX stock, worth $397,270. This represents 0.52% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$397,270
Previous $468,000 0.64%
% of portfolio
0.52%
Previous 0.57%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

BUY
$177.01 - $223.45 $177,010 - $223,450
1,000 New
1,000 $220,000
Q3 2021

Oct 25, 2021

SELL
$181.39 - $202.99 $181,390 - $202,990
-1,000 Closed
0 $0
Q4 2019

Feb 06, 2020

BUY
$166.71 - $223.91 $166,710 - $223,910
1,000 New
1,000 $219,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $102B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Wedgewood Investors Inc Portfolio

Follow Wedgewood Investors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedgewood Investors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Wedgewood Investors Inc with notifications on news.